These final results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the idea of targeting ACKR3 as a singular technique to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Issues. Conolidine promises to get a https://mitchh379tvo9.wikijournalist.com/user